Skip to content

Enterprise value at other companies

TFX
TeleflexTFX
$7.74B-2.0%
Boston Scientific logo
Boston ScientificBSX
$141.04B-1.0%
Intuitive Surgical logo
Intuitive SurgicalISRG
$197.54B+7.4%
Absci Corporation logo
Absci CorporationABSI
$453.38M+73.1%
UFP Technologies logo
UFP TechnologiesUFPT
$1.63B-6.0%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$4.66B+35.0%

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Gross profit$53.9M+22.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.19B-24.8%
P/S3.7×

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Calculated from PROCEPT BioRobotics Corporation’s reported figures.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's enterprise value?
PROCEPT BioRobotics Corporation (PRCT) reported enterprise value of $1.48B in Q1 2026.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.